Reference
Cautela J, et al. Acute Coronary Syndrome With Immune Checkpoint Inhibitors: A Proof-of-Concept Case and Pharmacovigilance Analysis of a Life-Threatening Adverse Event. Canadian Journal of Cardiology 36: 476-481, No. 4, Apr 2020. Available from: URL: http://doi.org/10.1016/j.cjca.2019.11.035
Rights and permissions
About this article
Cite this article
Antineoplastics/Antithymocte-globulin. Reactions Weekly 1801, 40 (2020). https://doi.org/10.1007/s40278-020-77700-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-77700-3